GlassScriptPhysician profile
Sana Hasan
NPI 1003071416
$1,140.10
in general payments reported to CMS, 2019-2025
15 companies · $325 in 2025
The $325 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.41 · 2020: $71.89 · 2021: $125 · 2022: $119 · 2023: $191 · 2024: $292 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $807.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $315.73 | 2020-2022 | |
| Novo Nordisk INC | $307.11 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $83.83 | 2024-2025 | Zepbound, Mounjaro |
| Medtronic, INC. | $73.66 | 2023-2025 | Minimed 780g |
| Corcept Therapeutics | $62.81 | 2024-2025 | Korlym |
| Ascendis Pharma Endocrinology INC | $60.16 | 2025 | Yorvipath |
| Dexcom, INC. | $55.94 | 2024 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $37.72 | 2024 | Recorlev, Gvoke Hypopen |
| Tandem Diabetes Care, INC. | $28.15 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Beta Bionics, INC. | $25.71 | 2024 | Ilet Bionic Pancreas |
| Amryt Pharma Holdings LTD | $23.50 | 2023 | Mycapssa |
| Recordati_rare_diseases_inc. | $17.91 | 2025 | Isturisa |
| Astrazeneca Pharmaceuticals LP | $17.04 | 2025 | Airsupra |
| Nalpropion Pharmaceuticals LLC | $16.41 | 2019 | |
| Rgh Enterprises LLC | $14.42 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sana Hasan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.